Motus GI got the green light to launch its Gen2 Pure-Vu System in Israel, the company announced April 7.
The Israeli Ministry of Health cleared commercial sales of the Pure-Vu system just weeks after Motus GI gained CE mark approval. The Israeli medical device market is one of the largest in the Middle East.
The Pure-Vu System is an FDA-approved bowel cleansing solution designed to improve visualization during colonoscopies.
"Given the large unmet need associated with insufficient bowel prep that exists throughout the world, we plan on continuing to assess potential partners who may be able to assist in scaling and accelerating our commercial footprint," Motus GI CEO Tim Moran said in a press release.